Skip to content

21 CFR Part 111 Subpart G (Components, Packaging, and Labels)

Regulatory

Also known as: Part 111 Subpart G, Supplement packaging CGMP, Packaging and labeling operations rule

The Part 111 regulations governing the components, packaging, and labels you receive for use in dietary supplements (written procedures, examination, and QC release before use). The packaging/labeling operations themselves are Subpart L.

What It Means

Subpart G of 21 CFR Part 111 (Sections 111.153-111.180) establishes requirements for the components, packaging, and labels you receive, and for product you receive for packaging or labeling as a dietary supplement. Key requirements include: written procedures for handling these materials (111.153), examination and documentation of components, packaging, and labels received (111.155-111.160), and quality-control release from quarantine before use (111.165). The packaging and labeling OPERATIONS themselves (filling, labeling, line controls, and label reconciliation) are governed separately by Subpart L (Sections 111.403-111.430). FDA's Compliance Program 7321.008 (updated August 18, 2025) includes a packaging/labeling-only inspection track for facilities that only package/label supplements (not manufacture). The Txsyn Int LLC warning letter (July 2024) is a canonical example of Subpart G failures: no written procedures, no QC release from quarantine for received product.

What It Is Not

Subpart G is about the components, packaging, and labels you RECEIVE; the packaging and labeling OPERATIONS themselves are Subpart L. It is distinct from Part 111's other subparts covering manufacturing operations (Subpart K), laboratory operations (Subpart J), and records (Subpart P). A facility can be FDA-registered for packaging/labeling only, without manufacturing capabilities.

Evidence and References

Related Categories

Need Help Understanding Compliance?

Our directory connects you with manufacturers and labs that meet these standards.